MARKET

IBB

IBB

iShares Biotechnology ETF
NASDAQ
133.38
-6.71
-4.79%
Closed 19:46 11/15 EST
OPEN
139.00
PREV CLOSE
140.09
HIGH
139.13
LOW
133.19
VOLUME
3.55M
TURNOVER
0
52 WEEK HIGH
150.36
52 WEEK LOW
113.47
TOTAL ASSET
6.55B
YTD YIELD
13.40%
1D
5D
1M
3M
1Y
5Y
1D
Continuously high dispersion in the markets could make it a ‘picker’s market’
Seeking Alpha · 2d ago
iShares Biotechnology Breaks Below 200-Day Moving Average - Notable for IBB
NASDAQ · 2d ago
IBB Crosses Critical Technical Indicator
NASDAQ · 2d ago
Fundamentals Vs. Politics: What Could Drive Markets Going Forward?
Seeking Alpha · 3d ago
Trump Names Anti-Vaxxer Robert Kennedy As Health & Human Services Secretary: Here’s What It Means For Healthcare Stocks
Barchart · 3d ago
Elliott Investment Management 13F Shows Exited Position In Marathon Petroleum, Previously Holding 7,365,000 Shares; Ishares Biotechnology ETF Put Position, Previously Holding 2,800,000 Shares; Invesco S&P 500 Equal Weight ETF Put Position, Previously Holding 1,925,000 Shares; Vaneck Gold Miners ETF Put Position, Previously Holding 5,000,000 Shares; BHP Group Ltd Call Position, Previously Holding 2,500,000 Shares; MicroStrategy Convertible Note, Previously Holding $27.5 Million In Principal
Benzinga · 3d ago
The U.S. Shakes Up Global Pharma Supply Chains
Seeking Alpha · 3d ago
Why Healthcare Investors Shouldn't Bank On Drug Pipelines
Seeking Alpha · 4d ago
More
Profile
Fund Name
iShares Biotechnology ETF
Inception Date
2001-02-05
Benchmark
ICE Biotechnology TR USD
Advisor Company
iShares
Custodian
JPMorgan Chase Bank, N.A.
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead